{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:33:25Z","timestamp":1773772405226,"version":"3.50.1"},"reference-count":27,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1134\/s1607672924700972","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T10:02:02Z","timestamp":1720864922000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence and Factors Associated with Coronary Heart Disease in Patients with Gout"],"prefix":"10.1134","volume":"517","author":[{"given":"E. L.","family":"Markelova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Eliseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Il\u2019inykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. I.","family":"Glukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"7542_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M. Dehlin","year":"2020","unstructured":"Dehlin, M., Jacobsson, L., and Roddy, E., Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors, Nat. Rev. Rheumatol., 2020, vol. 16, no. 7, pp. 380\u2013390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1","journal-title":"Nat. Rev. Rheumatol."},{"key":"7542_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"C.-F. Kuo","year":"2016","unstructured":"Kuo, C.-F., Grainge, M.J., Mallen, Ch., Zhang, W., and Doherty, M., Comorbidities in patients with gout prior to and following diagnosis: case-control study, Ann. Rheum. Dis., 2016, vol. 75, no. 1, pp. 210\u2013217. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206410","journal-title":"Ann. Rheum. Dis."},{"key":"7542_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T. Bardin","year":"2017","unstructured":"Bardin, T. and Richette, P., Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options, BMC Med., 2017, vol. 15, no. 1, p.\u00a0123. https:\/\/doi.org\/10.1186\/s12916-017-0890-9","journal-title":"BMC Med."},{"key":"7542_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/circulationaha.107.703389","volume":"116","author":"H.K. Choi","year":"2007","unstructured":"Choi, H.K. and Curhan, G., Independent impact of gout on mortality and risk for coronary heart disease, Circulation, 2007, vol. 116, no. 8, pp. 894\u2013900. https:\/\/doi.org\/10.1161\/circulationaha.107.703389","journal-title":"Circulation"},{"key":"7542_CR5","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E. Krishnan","year":"2006","unstructured":"Krishnan, E., Baker, J.F., Furst, D.E., and Schumacher, H.R., Gout and the risk of acute myocardial infarction, Arthritis Rheumatism, 2006, vol. 54, no. 8, pp.\u00a02688\u20132696. https:\/\/doi.org\/10.1002\/art.22014","journal-title":"Arthritis Rheumatism"},{"key":"7542_CR6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard.2009.122770","volume":"69","author":"M.A. De Vera","year":"2010","unstructured":"De Vera, M.A., Rahman, M.M., Bhole, V., Kopec, J.A., and Choi, H.K., Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study, Ann. Rheum. Dis., 2010, vol. 69, no. 6, pp. 1162\u20131164.","journal-title":"Ann. Rheum. Dis."},{"key":"7542_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/hpaa044","volume":"33","author":"L.G. Sanchez-Lozada","year":"2020","unstructured":"Sanchez-Lozada, L.G., Rodriguez-Iturbe, B., Kelley,\u00a0\u00a0E.E., Nakagawa, T., Madero, M., Feig, D.I., Borghi, C., Piani, F., Cara-Fuentes, G., Bjornstad, P., Lanaspa, M.A., and Johnson, R.J., Uric acid and hypertension: an update with recommendations, Am. J. Hypertens., 2020, vol. 33, no. 7, pp. 583\u2013594. https:\/\/doi.org\/10.1093\/ajh\/hpaa044","journal-title":"Am. J. Hypertens."},{"key":"7542_CR8","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M. Mazzali","year":"2002","unstructured":"Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K.L., Watanabe, S., Nakagawa, T., Lan, H.Y., and Johnson, R.J., Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism, Am. J. Physiol.: Renal Physiol., 2002, vol. 282, no. 6, pp.\u00a0F991\u2013F997. https:\/\/doi.org\/10.1152\/ajprenal.00283.2001","journal-title":"Am. J. Physiol.: Renal Physiol."},{"key":"7542_CR9","doi-asserted-by":"publisher","unstructured":"Park, J.J., Roudier, M.P., Soman, D., Mokadam, N.A., and Simkin, P.A., Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study, BMJ Open, 2014, vol. 4, no. 7, p. e005308. https:\/\/doi.org\/10.1136\/bmjopen-2014-005308","DOI":"10.1136\/bmjopen-2014-005308"},{"key":"7542_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P. Richette","year":"2017","unstructured":"Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Casta\u00f1eda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T.L., Janssens, H., Liot\u00e9, F., Mallen, C., Nuki, G., Perez-Ruiz, F., Pimentao, J., Punzi, L., Pywell, T., So, A., Tausche, A.K., Uhlig, T., Zavada, J., Zhang, W., Tubach, F., and Bardin, T., 2016 updated EULAR evidence-based recommendations for the management of gout, Ann. Rheum. Dis., 2017, vol. 76, no. 1, pp. 29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann. Rheum. Dis."},{"key":"7542_CR11","doi-asserted-by":"publisher","unstructured":"2020 Clinical Practice Guidelines for stable coronary artery disease, Ross. Kardiol. Zh., 2020, vol. 25, no. 11, p. 4076. https:\/\/doi.org\/10.15829\/29\/1560-4071-2020-4076","DOI":"10.15829\/29\/1560-4071-2020-4076"},{"key":"7542_CR12","doi-asserted-by":"publisher","unstructured":"2021 ESC Guidelines for cardiovascular disease prevention in clinical practice, Ross. Kardiol. Zh., 2022, vol. 27, no. 7, p. 5155. https:\/\/doi.org\/10.15829\/1560-4071-2022-5155","DOI":"10.15829\/1560-4071-2022-5155"},{"key":"7542_CR13","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy439","volume":"39","author":"B. Williams","year":"2018","unstructured":"Williams, B., Mancia, G., Spiering, W., Agabiti, R.E., et al., 2018 ESC\/ESH Guidelines for the management of arterial hypertension, Eur. Heart J., 2018, vol. 39, no.\u00a033, pp. 3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy439","journal-title":"Eur. Heart J."},{"key":"7542_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","volume":"81","author":"G.C. Drosos","year":"2022","unstructured":"Drosos, G.C., Vedder, D., Houben, E., Boekel, L., Atzeni, F., Badreh, S., Boumpas, D.T., Brodin, N., Bruce, I.N., Gonz\u00e1lez-Gay, M.\u00c1., Jacobsen, S., Kerekes, G., Marchiori, F., Mukhtyar, Ch., Ramos-Casals, M., Sattar, N., Schreiber, K., Sciascia, S., Svenungsson, E., Szekanecz, Z., Tausche, A.-K., Tyndall, A., Van Halm, V., Voskuyl, A., Macfarlane, G.J., Ward, M.M., Nurmohamed, M.T., and Tektoni-dou,\u00a0M.G., EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome, Ann. Rheum. Dis., 2022, vol. 81, no. 6, pp. 768\u2013779. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221733","journal-title":"Ann. Rheum. Dis."},{"key":"7542_CR15","doi-asserted-by":"publisher","unstructured":"Liu, S.-C., Xia, L., Zhang, J., Lu, X.-H., Hu, D.-K., Zhang, H.-T., and Li, H.-J., Gout and risk of myocardial infarction: a systematic review and meta-analysis of cohort studies, PLoS One, 2015, vol. 10, no. 7, p.\u00a0e0134088. https:\/\/doi.org\/10.1371\/journal.pone.0134088","DOI":"10.1371\/journal.pone.0134088"},{"key":"7542_CR16","first-page":"634","volume":"35","author":"K.H. Huang","year":"2019","unstructured":"Huang, K.H., Tai, C.J., Tsai, Y.F., Kuan, Y.H., and Lee, C.Y., Correlation between gout and coronary heart disease in taiwan: a nation-wide population-based cohort study, Acta Cardiol. Sin., 2019, vol. 35, no.\u00a06, pp. 634\u2013640.","journal-title":"Acta Cardiol. Sin."},{"key":"7542_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/clc.23266","volume":"42","author":"L. Liang","year":"2019","unstructured":"Liang, L., Hou, X., Bainey, K.R., Zhang, Ya., Tymchak, W., Qi, Zh., Li, W., and Banh, H.L., The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis, Clin. Cardiol., 2019, vol. 42, no. 11, pp. 1079\u20131086. https:\/\/doi.org\/10.1002\/clc.23266","journal-title":"Clin. Cardiol."},{"key":"7542_CR18","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/rheumatology\/keu239","volume":"53","author":"J.M.A. Wijnands","year":"2014","unstructured":"Wijnands, J.M.A., Boonen, A., Dagnelie, P.C., Van Greevenbroek, M.M.J., Van Der Kallen, C.J.H., Ferreira, I., Schalkwijk, C.G., Feskens, E.J.M., Stehouwer, C.D.A., Van Der Linden, S., and Arts, I.C.W., The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study, Rheumatology (Oxford), 2014, vol.\u00a053, no. 11, pp. 2053\u20132062. https:\/\/doi.org\/10.1093\/rheumatology\/keu239","journal-title":"Rheumatology"},{"key":"7542_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/rhu.0000000000000496","volume":"23","author":"M.N. Essex","year":"2017","unstructured":"Essex, M.N., Hopps, M., Bienen, E.J., Udall, M., Mardekian, J., and Makinson, G.T., Evaluation of the relationship between serum uric acid levels and cardiovascular events in patients with gout, J. Clin. Rheumatol., 2017, vol. 23, no. 3, pp. 160\u2013166. https:\/\/doi.org\/10.1097\/rhu.0000000000000496","journal-title":"J. Clin. Rheumatol."},{"key":"7542_CR20","doi-asserted-by":"publisher","first-page":"80688","DOI":"10.18632\/oncotarget.21079","volume":"8","author":"J. Wu","year":"2017","unstructured":"Wu, J., Lei, G., Wang, X., Tang, Yu., Cheng, H., Jian, G., Wu, X., and Wang, N., Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities, Oncotarget, 2017, vol. 8, no. 46, pp.\u00a080688\u201380699. https:\/\/doi.org\/10.18632\/oncotarget.21079","journal-title":"Oncotarget"},{"key":"7542_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N. Busso","year":"2010","unstructured":"Busso, N. and So, A., Mechanisms of inflammation in gout, Arthritis Res. Ther., 2010, vol. 12, no. 2, p. 206. https:\/\/doi.org\/10.1186\/ar2952","journal-title":"Arthritis Res. Ther."},{"key":"7542_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","volume":"17","author":"A.-M. Schjerning","year":"2020","unstructured":"Schjerning, A.-M., Mcgettigan, P., and Gislason, G., Cardiovascular effects and safety of (non-aspirin) NSAIDs, Nat. Rev. Cardiol., 2020, vol. 17, no. 9, pp.\u00a0574\u2013584. https:\/\/doi.org\/10.1038\/s41569-020-0366-z","journal-title":"Nat. Rev. Cardiol."},{"key":"7542_CR23","doi-asserted-by":"publisher","unstructured":"Yang, Ya., Xian, W., Wu, D., Huo, Z., Hong, Sh., Li,\u00a0Ya., and Xiao, H., The role of obesity, type 2 diabetes, and metabolic factors in gout: a Mendelian randomization study, Front. Endocrinol., 2022, vol. 13, p.\u00a0917056. https:\/\/doi.org\/10.3389\/fendo.2022.917056","DOI":"10.3389\/fendo.2022.917056"},{"key":"7542_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14341\/2071-8713-5263","volume":"3","author":"V.G. Barskova","year":"2006","unstructured":"Barskova, V.G., Il\u2019inykh, E.V., Eliseev, M.S., Zilov, A.V., and Nasonov, E.L., Cardiovascular risk in patients with gout, Ozhirenie Metab., 2006, vol. 3, no. 3, pp. 40\u201344. https:\/\/doi.org\/10.14341\/2071-8713-5263","journal-title":"Ozhirenie Metab."},{"key":"7542_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.47360\/1995-4484-2020-701-707","volume":"58","author":"E.I. Markelova","year":"2020","unstructured":"Markelova, E.I., Eliseev, M.S., Popkova, T.V., Ilinyh,\u00a0E.V., Glukhova, S.I., and Barskova, V.G., Prevalence and risk factors for the development of arterial hypertension in patients with gout, Nauchno-Prakt. \n               Revmatol., 2020, vol. 58, no. 6, pp. 701\u2013707. https:\/\/doi.org\/10.47360\/1995-4484-2020-701-707","journal-title":"Revmatol."},{"key":"7542_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","volume":"17","author":"M.J. Roughley","year":"2015","unstructured":"Roughley, M.J., Belcher, J., Mallen, Ch.D., and Roddy, E., Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies, Arthritis Res. Ther., 2015, vol. 17, no. 1, p. 90. https:\/\/doi.org\/10.1186\/s13075-015-0610-9","journal-title":"Arthritis Res. Ther."},{"key":"7542_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/ar3806","volume":"14","author":"K.-H. Yu","year":"2012","unstructured":"Yu, K.-H., Kuo, C.-F., Luo, S.-F., See, L.-C., Chou,\u00a0I.J., Chang, H.-C., and Chiou, M.-J., Risk of end-stage renal disease associated with gout: a nationwide population study, Arthritis Res. Ther., 2012, vol.\u00a014, no. 2, p. 83. https:\/\/doi.org\/10.1186\/ar3806","journal-title":"Arthritis Res. Ther."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672924700972","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:17:54Z","timestamp":1773760674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672924700972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7542"],"URL":"https:\/\/doi.org\/10.1134\/s1607672924700972","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"The study was approved by the Ethics Committee of the Nasonova Research Institute of Rheumatology within the framework of topic no. 304 \u201cModern treatment of gout and its course\u201d (protocol no. 19 of September 18, 2009). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}}]}}